The transactions highlighted below are representative of Greenhill engagements. In addition, the Firm has completed many engagements that were not publicly-disclosed.
Recent Transactions
Sort By
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
U.S. Acute Care Solutions
![flag not available](https://www.greenhill.com/sites/default/files/n_a_flag.gif)
Advised U.S. Acute Care Solutions, the largest majority physician-owned emergency medicine practice in the United States, on the refinancing of its senior secured notes
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Functional Formularies
![France France flag](https://www.greenhill.com/sites/default/files/france.gif)
Advised Danone on its acquisition of Functional Formularies, a leading whole foods tube feeding business in the US, from Swander Pace Capital
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Tegra’s Operating Entities in Honduras, El Salvador, and the U.S.
![South Korea Korea flag](https://www.greenhill.com/sites/default/files/Korea.jpg)
Advising Tegra, a premier and leading near and onshore apparel manufacturer for sport, team, and performance apparel, on the sale of its operating entities in Honduras, El Salvador, and the U.S. to SAE-A Trading, a vertically integrated textile and apparel garment manufacturer
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
illion Australia Pty Ltd
![United Kingdom United Kingdom flag](https://www.greenhill.com/sites/default/files/uk.gif)
Advising Experian Plc, the world’s leading global information services company, on the acquisition of illion Australia Pty Ltd, one of Australasia's leading consumer and commercial credit bureaus
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Equity Interest in ARM Energy Trading
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advising Tokyo Gas America on the acquisition of a 49% equity interest stake in ARM Energy Holding’s producer services and wholesale commodity trading business, ARM Energy Trading. Tokyo Gas America is an energy company that engages in a wide range of businesses, including operated gas and oil assets, midstream, downstream, power generation, natural gas distribution, and LNG exportation
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
QuarterNorth Energy Inc.
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advising Talos Energy, an independent exploration and production company, on the acquisition of QuarterNorth Energy, a privately held offshore Gulf of Mexico E&P operator with working interests in several prolific deepwater U.S. Gulf of Mexico assets
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Rockcliff Energy II LLC
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advising TG Natural Resources on the acquisition of Rockcliff Energy II LLC, a portfolio company of Quantum Energy Partners (“Quantum”). Rockcliff is a premier natural gas company in the prolific East Texas Haynesville shale and one of the top natural gas producers in the state of Texas. TG Natural Resources is a Houston based, private E&P company with operations focused in the Haynesville Shale and majority owned by Tokyo Gas
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Vopak Moda Houston
![Spain Spain flag](https://www.greenhill.com/sites/default/files/spain.gif)
Advising Exolum on its acquisition of 50% interest in Vopak Moda Houston, a leading ammonia and NGL storage & export terminal, from Moda Midstream (Encap Flatrock-Backed)
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Sonoma-Cutrer Vineyards (Brown-Forman)
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised Brown-Forman, the largest American-owned spirits and wine company, on its sale of Sonoma-Cutrer Vineyards to The Duckhorn Portfolio
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Minerals and Royalties Interest
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised a company on the sale of its minerals and royalties interests in the Appalachian Basin
![France France flag](https://www.greenhill.com/sites/default/files/france.gif)
Innergex France
![France France flag](https://www.greenhill.com/sites/default/files/france.gif)
Advised Crédit Agricole Assurances, France’s largest insurance Group, in relation to its long-term partnership agreement with Innergex Renewable Energy Inc. (TSX: INE) and the acquisition of a 30% minority stake in Innergex France, the French operating and development activities of Innergex Renewable Energy Inc, for an enterprise value of €715m (@ 100%)
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Slayback Pharma LLC
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised Azurity Pharmaceuticals, a pharmaceutical company specializing in the provision of innovative medicines to overlooked patients, on the acquisition of Slayback Pharma LLC ("Slayback"), a company focused on complex generic and specialty pharmaceutical products
![United Kingdom United Kingdom flag](https://www.greenhill.com/sites/default/files/uk.gif)
Clinigen Ltd’s portfolio of Established Medicines
![United Kingdom United Kingdom flag](https://www.greenhill.com/sites/default/files/uk.gif)
Advised Clinigen Ltd, a UK-based global pharmaceutical services company and portfolio company of Triton Partners, on the sale of a portfolio of Established Medicines to CNX Therapeutics, a UK-based European pharma company owned by Inflexion Partners
![Spain Spain flag](https://www.greenhill.com/sites/default/files/spain.gif)
Farmalider Group
![Spain Spain flag](https://www.greenhill.com/sites/default/files/spain.gif)
Advising the shareholders of Grupo Farmalider, a B2B Spanish pharmaceutical company focused on contract manufacturing, innovation and development of products based on generics, on the sale of an undisclosed stake to local private equity MCH
![USA/UK U.S.A., U.K. flags](https://www.greenhill.com/sites/default/files/usa_uk.gif)
Juice Plus+
![flag not available](https://www.greenhill.com/sites/default/files/n_a_flag.gif)
Advised Juice Plus+, a global health and wellness company in the direct selling space on a comprehensive recapitalization transaction
![United Kingdom United Kingdom flag](https://www.greenhill.com/sites/default/files/uk.gif)
Lookers Plc
![Canada Canada flag](https://www.greenhill.com/sites/default/files/canada.gif)
Advising JerseyCo, the indirect Holdco of Alpha Auto Group, a Canadian automotive dealership group, on its acquisition of Lookers Plc, a leading UK automotive dealership group
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Interest in Joint Venture with CarepathRx Health System Solutions
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advising Cigna on its investment in CarepathRx Health System Solutions, under Evernorth, Cigna’s health services subsidiary
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
Marley Spoon business combination with 468 SPAC II
![Germany Germany flag](https://www.greenhill.com/sites/default/files/germany.gif)
Advising Marley Spoon SE, an ASX listed global subscription-based meal kit provider, on its business combination agreement with 468 SPAC II, simultaneous capital raising and amendment to existing debt facilities
![United Kingdom United Kingdom flag](https://www.greenhill.com/sites/default/files/uk.gif)
Kyowa Kirin International’s testosterone replacement therapy drug, Tostran®
![United Kingdom United Kingdom flag](https://www.greenhill.com/sites/default/files/uk.gif)
Advising Kyowa Kirin International, a subsidiary of Kyowa Kirin Co., Ltd, a Japanese global specialty pharma company, on the divestiture of its testosterone replacement therapy drug, Tostran®, to Advanz Pharma, a privately-held, specialty pharmaceutical company
![Sweden Sweden flag](https://www.greenhill.com/sites/default/files/sweden.gif)
Scandinavian Enviro Systems AB
![France France flag](https://www.greenhill.com/sites/default/files/france.gif)
Advising Enviro on the creation of the world’s first large-scale tire recycling group in a JV with Antin Infrastructure Partners, supported by Michelin
![](https://www.greenhill.com/sites/default/files/greece-uk.png)
Clinigen Ltd’s Lamda Laboratories
![Germany Germany flag](https://www.greenhill.com/sites/default/files/germany.gif)
Advising Clinigen Ltd, a UK-based global pharmaceutical services company and portfolio company of Triton Partners, on the sale of Lamda Laboratories, a European contract development business, to Adragos Pharma, a Munich-based pharmaceutical CDMO
![USA/UK U.S.A., U.K. flags](https://www.greenhill.com/sites/default/files/usa_uk.gif)
Flavor Specialty Ingredients division of IFF
![United Kingdom United Kingdom flag](https://www.greenhill.com/sites/default/files/uk.gif)
Sole financial adviser to Exponent, one of the UK’s leading private equity firms, on the acquisition of IFF’s Flavor Specialty Ingredients division, a global leader in the base aromas market
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Gaming Services Division of Global Payments
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advising Parthenon Capital, a financial services & technology focused private equity firm, on its acquisition of Global Payment’s Gaming Services Division, a leading provider of on-site and digital payment processing services to companies in the gaming industry, for $415mm
![United Kingdom United Kingdom flag](https://www.greenhill.com/sites/default/files/uk.gif)
Clinigen Ltd’s Proleukin
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advising Clinigen Ltd, a UK-based global pharmaceutical services company and portfolio company of Triton Partners, on the sale of Proleukin (Interleukin-2 (Aldesleukin)), to Iovance Biotherapeutics, a late-stage biotechnology company developing novel T cell-based cancer immunotherapies
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Annovera®, Imvexxy®, Bijuva®, and prescription prenatal vitamin products
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
Advised TherapeuticsMD, Inc., an innovative, leading women’s healthcare company on definitive agreements to license its products to Mayne Pharma